Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
732.00Today’s High
758.5052W low
318.8052W High
775.00Open Price
738.00Prev. Close
720.5000Volume
190419.00Value
142719040.50Fundamentals
Market Cap Cr
11938.10
Price to Earnings
154.80
Price to Book Value
2.20
Dividend Yield
0.70
PE to Growth
0.70
Op Revenue TTM Cr
6702.90
Net Profit TTM Cr
77.10
Cash From Operating Activity Cr
971.30
Return on Equity %
1.41
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 Jul, 2024
54.4
Week
52
Month
44.5
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
746.68
PIVOT
First Resistance
761.32
Second Resistance
773.13
Third Resistance
787.77
First Support
734.87
Second Support
720.23
Third Support
708.42
Relative Strength Index
58.02
Money Flow Index
41.63
MACD
9.67
MACD Signal
10.6
Average True Range
27.54
Average Directional Index
15.03
Rate of Change (21)
16.94
Rate of Change (125)
29.68
Commodity Channel Index
73.3
Williams %R
-34.9
BETA
1 Month
0.94
3 Month
0.74
1 Year
0.72
3 Year
0.47
PRICE CHANGE ANALYSIS
↑ 1.65%
1 Week
Low
High
721.3
770
↑ 11.59%
1 Month
Low
High
617.05
775
↑ 29.36%
3 Months
Low
High
580.45
775
↑ 29.26%
6 Months
Low
High
532.15
775
↑ 86.12%
1 Year
Low
High
318.75
775
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 255.90 | 194.20 | 204.70 | 233.30 | 213.50 | 190.61 | 329.09 | 214.81 | 35.89 | 27.25 | 126.11 | |
| Operating Expenses Qtr | 193.60 | 175.90 | 185.50 | 213.20 | 197.66 | 184.63 | 215.67 | 208.94 | 30.38 | 24.02 | 22.88 | |
| Operating Profit Qtr | 12.20 | -0.70 | 0.80 | 4.20 | 2.18 | -1.89 | 7.30 | -4.37 | -1.59 | -5.35 | -2.85 | |
| EBIDT Qtr Cr | 62.30 | 18.30 | 19.20 | 20.10 | 15.84 | 5.98 | 113.42 | 5.87 | 5.51 | 3.23 | 103.23 | |
| Depreciation Qtr | 12.70 | 12.30 | 11.90 | 11.40 | 11.37 | 11.59 | 11.08 | 9.21 | 1.59 | 1.60 | 1.54 | |
| Net Profit Qtr | 32.50 | -2.40 | -0.40 | 1.90 | -30.86 | -5.89 | 91.81 | -5.18 | -3.11 | -5.34 | 88.08 | |
| Basic EPS Qtr | 2.05 | -0.15 | -0.03 | 0.12 | -1.94 | -0.37 | 5.77 | -0.33 | -0.19 | -0.34 | 5.53 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 888.10 | 948.01 | 213.62 | 2757.38 | 3313.13 | |
| Operating Expenses Annual Cr | 768.20 | 806.89 | 94.53 | 2282.44 | 2769.00 | |
| Operating Profit Annual | 16.50 | 3.23 | -6.79 | 427.06 | 370.90 | |
| Operating Profit Margin Annual % | 1.86 | 0.34 | -3.18 | 15.49 | 11.19 | |
| Total Expenses Annual Cr | 846.40 | 868.66 | 131.37 | 2484.21 | 3012.59 | |
| EBIDT Annual Cr | 119.90 | 141.12 | 119.08 | 474.94 | 544.13 | |
| EBIDT Annual margin % | 13.50 | 14.89 | 55.75 | 17.22 | 16.42 | |
| Depreciation | 48.30 | 43.25 | 6.25 | 99.97 | 107.40 | |
| PAT Before ExtraOrdinary Items Annual Cr | 31.60 | 49.88 | 78.50 | 214.47 | 321.14 | |
| Net Profit Annual | 31.60 | 49.88 | 78.50 | 214.47 | 321.14 | |
| Basic EPS Annual | 1.99 | 3.13 | 4.93 | 13.47 | 20.16 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 2374.50 | 2414.55 | 1281.82 | 1282.44 | 2607.30 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 302.00 | 232.72 | 509.97 | 442.00 | 1450.86 | |
| Total Current Liabilities Annual Cr | 315.40 | 361.19 | 37.68 | 120.15 | 1375.23 | |
| Total Capital Plus Liabilities Annual Cr | 2991.90 | 3008.47 | 1829.47 | 1844.60 | 5433.39 | |
| Fixed Assets Annual | 698.50 | 734.37 | 123.60 | 127.41 | 1923.81 | |
| Total Non Current Assets Annual | 2451.30 | 2429.59 | 1781.57 | 1778.35 | 3711.26 | |
| Total Current Assets Annual | 540.60 | 578.88 | 47.90 | 66.25 | 1722.13 | |
| Total Assets Annual | 2991.90 | 3008.47 | 1829.47 | 1844.60 | 5433.39 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 116.26 | 69.70 | 70.39 | 478.39 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 143.20 | -65.11 | -3.55 | 608.38 | 316.76 | |
| Cash from Investing Activity Annual | -40.30 | 31.07 | 93.10 | 177.96 | -197.71 | |
| Cash from Financing Annual Activity | -77.80 | 22.51 | -107.37 | -781.64 | -41.05 | |
| Net Cash Flow Annual | - | -11.53 | -17.82 | 4.69 | 78.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 149.34 | 151.57 | 80.47 | 80.50 | 163.67 | |
| ROE Annual % | 1.33 | 2.06 | 6.12 | 16.72 | 12.31 | |
| ROCE Annual % | 2.67 | 3.69 | 6.29 | 21.74 | 10.76 | |
| Total Debt to Total Equity Annual | 0.14 | 0.12 | 0.39 | 0.38 | 0.75 | |
| EBDIT Annual Margin % | 15.27 | 17.41 | 135.70 | 17.52 | 17.32 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1773.00 | 1712.90 | 1690.20 | 1595.50 | 1682.45 | 1561.98 | 1612.60 | 1463.03 | 1524.57 | 1316.44 | 1661.90 | |
| Operating Expenses Qtr | 1487.20 | 1459.10 | 1438.50 | 1417.30 | 1458.78 | 1406.63 | 1380.75 | 1259.32 | 1280.18 | 1116.29 | 1317.95 | |
| Operating Profit Qtr | 271.40 | 218.00 | 241.80 | 169.60 | 219.22 | 145.88 | 218.75 | 192.40 | 234.26 | 194.24 | 339.50 | |
| EBIDT Qtr Cr | 116.90 | 253.80 | 251.70 | 178.20 | 223.67 | 155.35 | 175.03 | 203.71 | 244.39 | 200.15 | 343.95 | |
| Depreciation Qtr | 101.00 | 94.60 | 96.60 | 89.70 | 271.23 | 94.28 | 93.95 | 94.57 | 100.55 | 93.33 | 99.78 | |
| Net Profit Qtr | -58.60 | 66.80 | 62.50 | 6.40 | -97.84 | -15.67 | 5.49 | 47.04 | 59.55 | 50.99 | 142.84 | |
| Basic EPS Qtr | -3.69 | 4.22 | 3.94 | 0.40 | -6.15 | -0.98 | 0.34 | 2.96 | 3.74 | 3.20 | 8.97 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 6771.60 | 6320.06 | 6141.45 | 6116.17 | 6013.20 | |
| Operating Expenses Annual Cr | 5802.10 | 5505.49 | 4973.83 | 4702.07 | 4427.84 | |
| Operating Profit Annual | 900.80 | 776.24 | 1156.33 | 1396.46 | 1547.95 | |
| Operating Profit Margin Annual % | 13.30 | 12.28 | 18.83 | 22.83 | 25.74 | |
| Total Expenses Annual Cr | 6456.30 | 6247.71 | 5501.02 | 5235.12 | 4967.39 | |
| EBIDT Annual Cr | 969.50 | 814.57 | 1167.62 | 1414.10 | 1585.36 | |
| EBIDT Annual margin % | 14.32 | 12.89 | 19.01 | 23.12 | 26.36 | |
| Depreciation | 381.90 | 554.03 | 381.70 | 348.95 | 339.84 | |
| PAT Before ExtraOrdinary Items Annual Cr | 48.60 | -77.13 | 423.00 | 562.61 | 677.77 | |
| Net Profit Annual | 77.10 | -60.98 | 413.94 | 835.87 | 898.25 | |
| Basic EPS Annual | 4.87 | -3.83 | 26.00 | 52.48 | 56.39 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 5433.90 | 5399.28 | 5318.56 | 4741.49 | 5603.88 | |
| Minority Interest Liability Annual Cr | -12.80 | -7.49 | -2.16 | 0.03 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 4238.40 | 3992.46 | 3082.87 | 3127.76 | 4298.76 | |
| Total Current Liabilities Annual Cr | 1889.00 | 1772.40 | 1591.60 | 1048.83 | 2619.01 | |
| Total Capital Plus Liabilities Annual Cr | 11548.50 | 11156.65 | 9990.87 | 8918.11 | 12521.65 | |
| Fixed Assets Annual | 4453.40 | 4316.16 | 3717.42 | 3375.78 | 5018.90 | |
| Total Non Current Assets Annual | 7672.40 | 7394.25 | 6481.68 | 5965.61 | 7483.30 | |
| Total Current Assets Annual | 3876.10 | 3762.40 | 3509.19 | 2952.50 | 5038.35 | |
| Total Assets Annual | 11548.50 | 11156.65 | 9990.87 | 8918.11 | 12521.65 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 1151.49 | 842.82 | 887.12 | 1160.58 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 971.30 | 660.67 | 837.54 | 1784.27 | 1542.94 | |
| Cash from Investing Activity Annual | -607.90 | -544.41 | -380.37 | -739.01 | -327.00 | |
| Cash from Financing Annual Activity | -432.50 | -156.68 | -32.60 | -1709.39 | -1050.37 | |
| Net Cash Flow Annual | - | -40.43 | 424.57 | -664.13 | 165.56 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 343.11 | 338.91 | 333.97 | 297.85 | 351.78 | |
| ROE Annual % | 1.41 | -1.12 | 7.78 | 17.62 | 16.02 | |
| ROCE Annual % | 6.08 | 2.77 | 9.35 | 13.53 | 12.57 | |
| Total Debt to Total Equity Annual | 0.63 | 0.63 | 0.55 | 0.54 | 0.78 | |
| EBDIT Annual Margin % | 14.46 | 12.96 | 19.04 | 23.18 | 26.52 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ABAKKUS EMERGING OPPORTUNITIES FUND-1 | 1.2 | 75060727 | - | - |
| EAST BRIDGE CAPITAL MASTER FUND LIMITED | 4.27 | 75060731 | - | - |
| GOVERNMENT PENSION FUND GLOBAL | 3.76 | 75060732 | - | - |
| EAST BRIDGE CAPITAL MASTER FUND I LTD | 3.17 | 75060733 | - | - |
| REKHA JHUNJHUNWALA | 6.64 | 75060744 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| PRIYAVRAT BHARTIA | 0.88 | 75060701 | 0 | 0 |
| SPB TRUSTEE COMPANY PVT LTD | 20.52 | 75060706 | 0 | 0 |
| HSB TRUSTEE COMPANY PVT LTD | 19 | 75060707 | 0 | 0 |
| MILLER HOLDINGS PTE LTD | 3.28 | 75060716 | 0 | 0 |
| MAV MANAGEMENT ADVISORS LLP | 3.15 | 75060708 | 0 | 0 |
| NIKITA RESOURCES PRIVATE LIMITED | 2.2 | 75060709 | 0 | 0 |
| JUBILANT ENPRO PRIVATE LIMITED | 1.33 | 75060710 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| QUANT MUTUAL FUND - QUANT FLEXI CAP FUND | 1.75 | 75060724 |
| EAST BRIDGE CAPITAL MASTER FUND LIMITED | 4.27 | 75060731 |
| GOVERNMENT PENSION FUND GLOBAL | 3.76 | 75060732 |
| EAST BRIDGE CAPITAL MASTER FUND I LTD | 3.17 | 75060733 |
| THELEME INDIA MASTER FUND LIMITED | 1.17 | 75060734 |
| ABAKKUS EMERGING OPPORTUNITIES FUND-1 | 1.2 | 75060727 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| REKHA JHUNJHUNWALA | 6.64 | 75060744 |
| INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS | 1.24 | 75060747 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Aug 10, 2023 | 5 | FINAL | Aug 10, 2023 | Equity Share |
| Aug 11, 2022 | 5 | FINAL | Aug 12, 2022 | Equity Share |
| Aug 05, 2021 | 5 | FINAL | Aug 06, 2021 | Equity Share |
| Mar 09, 2020 | 5 | INTERIM | Mar 11, 2020 | Equity Share |
| Sep 12, 2019 | 4.5 | FINAL | - | Equity Share |
| Sep 12, 2018 | 3 | FINAL | - | Equity Share |
| Aug 16, 2017 | 3 | FINAL | - | Equity Share |
| Aug 18, 2016 | 3 | FINAL | - | Equity Share |
| Aug 20, 2015 | 3 | FINAL | - | Equity Share |
| Aug 21, 2014 | 3 | FINAL | - | Equity Share |
| Aug 14, 2013 | 3 | FINAL | - | Equity Share |
| Aug 14, 2012 | 3 | FINAL | - | Equity Share |
| Aug 10, 2011 | 2 | FINAL | - | Equity Share |
| Sep 17, 2010 | 2 | FINAL | - | Equity Share |
| Jun 29, 2009 | 1.5 | FINAL | - | Equity Share |
| Sep 17, 2008 | 1.5 | FINAL | - | Equity Share |
| Sep 17, 2007 | 1.25 | FINAL | - | Equity Share |
| Sep 08, 2006 | 1.25 | FINAL | - | Equity Share |
| Aug 22, 2005 | 6.25 | FINAL | - | Equity Share |
| Sep 06, 2004 | 1.25 | FINAL | - | Equity Share |
| Jan 23, 2004 | 3.75 | INTERIM | Jan 27, 2004 | Equity Share |
| Sep 04, 2002 | - | FINAL | - | Equity Share |
| Aug 28, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Mar 17, 2006 | 5:1 | 2006-03-24 |
| Nov 12, 2002 | 10:5 | 2002-11-21 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 29, 2024 | Audited Results & Final Dividend | - |
| Feb 02, 2024 | Quarterly Results | - |
| Oct 27, 2023 | Quarterly Results | - |
| Jul 19, 2023 | Quarterly Results | - |
| May 29, 2023 | Audited Results & Final Dividend | - |
| Feb 03, 2023 | Quarterly Results | - |
| Oct 21, 2022 | Quarterly Results | - |
| Aug 02, 2022 | Quarterly Results | - |
| May 27, 2022 | Audited Results & Final Dividend | - |
| Feb 04, 2022 | Quarterly Results | - |
| Oct 22, 2021 | Quarterly Results | - |
| Jul 23, 2021 | Quarterly Results | - |
| Jun 04, 2021 | Audited Results & Final Dividend | - |
| Feb 05, 2021 | Quarterly Results | - |
| Nov 04, 2020 | Quarterly Results & Others | Inter alia, to consider The proposal to issue Non-Convertible Debentures upto Rs. 100 Crore. |
| Sep 04, 2020 | Quarterly Results | - |
| May 29, 2020 | Audited & Quarterly Results | Inter alia, to consider Issue of Non-Convertible Debentures upto Rs. 100 Crore. |
| Feb 27, 2020 | Interim Dividend | - |
| Jan 31, 2020 | Quarterly Results | - |
| Oct 25, 2019 | Quarterly Results | - |
| Jul 26, 2019 | Quarterly Results | - |
| May 17, 2019 | Audited Results & Final Dividend | - |
| Feb 01, 2019 | Quarterly Results | - |
| Oct 22, 2018 | Quarterly Results | - |
| Jul 27, 2018 | Quarterly Results | - |
| Jun 27, 2018 | Others | Consider the proposal to issue Non-Convertible Debentures up to an amount of Rs. 750 Crore. |
| May 09, 2018 | Audited Results & Dividend | - |
| Jan 17, 2018 | Quarterly Results | - |
| Oct 28, 2017 | Quarterly Results | - |
| Jul 18, 2017 | Quarterly Results | - |
| May 23, 2017 | Audited Results & Dividend | - |
| Feb 07, 2017 | Quarterly Results | - |
| Oct 27, 2016 | Quarterly Results | - |
| Aug 09, 2016 | Quarterly Results | - |
| May 24, 2016 | Audited Results & Dividend | - |
| Feb 09, 2016 | Quarterly Results | - |
| Oct 29, 2015 | Allotment of Shares | The Board has accorded approval for raising funds through issue of Equity / GDRs / ADRs / FCCBs or other equity related instruments upto an amount of USD 200 million [Rs. 1300 crores (approx.)]. |
| Aug 11, 2015 | Quarterly Results | - |
| May 12, 2015 | Audited Results & Dividend | - |
| Feb 03, 2015 | Quarterly Results | - |
| Oct 28, 2014 | Quarterly Results | - |
| Aug 05, 2014 | Quarterly Results | - |
| May 26, 2014 | Audited Results & Dividend | - |
| Feb 06, 2014 | Quarterly Results | - |
| Oct 29, 2013 | Quarterly Results | - |
| Aug 01, 2013 | Quarterly Results | - |
| May 07, 2013 | Audited Results & Dividend | - |
| Jan 29, 2013 | Quarterly Results | - |
| Nov 05, 2012 | Quarterly Results | - |
| Jul 23, 2012 | Quarterly Results | - |
| May 07, 2012 | Audited Results & Dividend | - |
| Feb 06, 2012 | Quarterly Results | - |
| Nov 01, 2011 | Quarterly Results | - |
| Aug 09, 2011 | Quarterly Results | - |
| May 10, 2011 | Audited Results & Dividend | - |
| Feb 14, 2011 | Quarterly Results | - |
| Nov 11, 2010 | Quarterly Results | (Revised) |
| Jul 27, 2010 | Quarterly Results | - |
| Jul 08, 2010 | Scheme of Arrangement | The BoD has approved a SoA & Demerger among Jubilant Organosys Ltd., Speciality Molecules Ltd., Pace Marketing Specialities Ltd. & Jubilant Industries Ltd. & their respective Shareholders & Creditors. |
| May 10, 2010 | Audited Results & Dividend | - |
| Jan 21, 2010 | Raising of Additional Capital & Others | For raising additional Capital through issue of Securities or other Equity related instruments or Equity related instruments to QIBs of Rs. 1000 Crs & Demerger of its Agri and Performance Polymer. |
| Oct 22, 2009 | Raising of Capital & Others | To consider raising of capital through issue of Equity or Equity related instruments upto Rs 500 Crs & to change the name of the Company from "Jubilant Organosys Ltd" to "Jubilant Life Sciences Ltd". |
| Jul 14, 2009 | Quarterly Results | - |
| Apr 28, 2009 | Audited Results & Dividend | - |
| Jan 27, 2009 | Quarterly Results | - |
| Oct 14, 2008 | Quarterly Results | - |
| Jul 15, 2008 | Quarterly Results | - |
| Apr 22, 2008 | Audited Results & Dividend | - |
| Jan 30, 2008 | Quarterly Results | (Revised) |
| Oct 16, 2007 | Quarterly Results | - |
| Jul 17, 2007 | Quarterly Results | - |
| Apr 27, 2007 | Audited Results & Dividend | - |
| Jan 16, 2007 | Quarterly Results | - |
| Oct 17, 2006 | Quarterly Results | - |
| Jul 18, 2006 | Quarterly Results | - |
| Apr 18, 2006 | Accounts & Dividend | - |
| Jan 14, 2006 | Quarterly Results | - |
| Oct 28, 2005 | Quarterly Results | - |
| Oct 03, 2005 | Allotment of equity shares | Allotment of 13689 equity shares of Rs.5/- each at a premium of Rs.813.23 per share has been made to Merill Lynch capital markets Espana S.A SV. |
| Sep 06, 2005 | General | The Board of Directors of the Company has allotted 9,90,000 equity shares of Rs 5/- each at a premium of Rs 1095/- to GA European Investments Ltd. |
| Aug 04, 2005 | Allotment of equity shares | Board has alloted 68447 equity shares of Rs. 5 /- each at a premium of Rs. 813.23 per share to Photon Mauritius Ltd. on conversion of a part of FCCB amounting To US $ 1250000. |
| Jul 30, 2005 | Quarterly Results | - |
| Jul 14, 2005 | Allotment of equity shares | Board has alloted of 41,068 equity shares of Rs 5/- each at a premium of Rs 813.23 per share has been made to Merrill Lynch Capital Markets Espana SA, SV & ABN AMRO Bank NV. |
| Apr 16, 2005 | Dividend & Accounts | - |
| Apr 04, 2005 | A proposal to raise funds & Others | To consider a proposal for acquisition of a Generic pharmaceutical Company in USA. |
| Jan 29, 2005 | Quarterly Results | - |
| Oct 30, 2004 | Quarterly Results | - |
| Sep 21, 2004 | Others | To consider investment in equity of Jubilant Clinsys Ltd and Jubilant Chemsys Ltd so as to make them wholly owned subsidiaries and to focus on the growth in clinical research and chemistry services. |
| Jul 27, 2004 | Quarterly Results | - |
| Apr 28, 2004 | Accounts & Final Dividend | for the year 31-03-2004 |
| Apr 22, 2004 | Others | Consider opportunities for business expansion including those through International acquisitions projects. |
| Feb 03, 2004 | Others | a) To consider acquisition of equity shares in jubilant Biosys Ltd. (JBL) in order to convert JBL in to a subsidiary of the Company. |
| Jan 09, 2004 | Quarterly Results & Interim Dividend | - |
| Oct 11, 2003 | Quarterly Results | - |
| Jul 29, 2003 | Quarterly Results | - |
| May 09, 2003 | Accounts, Dividend & Others | Sub Division of Equity shares and alteration of capital clause of M&A of the compay. |
| Feb 05, 2003 | Others | Business expansion including those through acuisition. |
| Jan 30, 2003 | Quarterly Results | - |
| Oct 22, 2002 | Quarterly Results | - |
| Sep 04, 2002 | Others | Considering opportunities for business expansion including those through acquisition. |
| Jul 17, 2002 | Quarterly Results & Others | Merger of Vam Leasing and Vam Investments Ltd. with the Company & Sub Division of Equity shares and alteration of capital clause of Memorandum & articles of Association of the Co. |
| May 03, 2002 | Accounts & Dividend | - |
| Jan 22, 2002 | Quarterly Results | - |
| Oct 25, 2001 | Quarterly Results | - |
| Sep 03, 2001 | Others | Allotment of Fully convertible equity warrants to promoters of the company and/or their nominees on preferential basis |
| Jul 25, 2001 | Quarterly Results | - |
| Jun 28, 2001 | Accounts & Dividend | - |
| May 21, 2001 | Others | Allotment of Fully convertible equity warrants to promoters of the company and/or their nominees on preferential basis |
| Jan 30, 2001 | Quarterly Results | - |
| Dec 08, 2000 | Preferential Offer | Allotment of Fully Convertible equity warrants to promoters on preferential basis. |
| Oct 30, 2000 | Quarterly Results | - |
| Jul 27, 2000 | Quarterly Results | - |
| Jun 29, 2000 | Accounts & Dividend | - |
| Jun 28, 2000 | Accounts & Dividend (Revised) | - |
| May 27, 2000 | Accounts & Dividend | - |
| Jan 27, 2000 | Quarterly Results | - |
| Oct 28, 1999 | Quarterly Results | - |
| Jul 26, 1999 | Quarterly Results | - |
| May 27, 1999 | Accounts & Dividend | - |
| Oct 24, 1998 | Quarterly Results | - |
| Oct 16, 1998 | Others | - |
| Jul 31, 1998 | Revised | - |
| Jul 30, 1998 | Quarterly Results | - |
| Jun 29, 1998 | Accounts & Dividend | - |
| Nov 24, 1997 | Half Yearly Results | - |
| Jun 27, 1997 | Accounts & Dividend | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Mar 12, 2004 | 3:5 | 2004-03-15 |
26 Jun 2024
Jubilant Pharmova Ltd - 530019 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Outcome of Postal Ballot - Scrutinizer''s Report and Voting Results
25 Jun 2024
Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Disclosure for Loss of Share Certificate
25 Jun 2024
Jubilant Pharmova Ltd - 530019 - Disclosure For Completion Of Voluntary Prepayment Of USD 75 Million Term Loan, Equivalent To Rs. 626 Cr
Disclosure for completion of volunary prepayment of USD 75 million term loan, equivalent to Rs. 626 Cr.
23 Jun 2024
Jubilant Pharmova Ltd - 530019 - Closure of Trading Window
Intimation for closure of Trading Window
20 Jun 2024
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication - Communication to Shareholders
18 Jun 2024
Jubilant Pharmova Ltd - 530019 - Announcement Under Regulation 30 - Communication From USFDA
Announcement under Regulation 30 - Communication from USFDA
14 Jun 2024
Jubilant Pharmova Ltd - 530019 - Investment To Expand Positron Emission Tomography (PET) Radiopharmacy Network
Disclosure for investment to expand Positron Emission Tomography (PET) Radiopharmacy Network
14 Jun 2024
Jubilant Pharmova Ltd - 530019 - Disclosure For Voluntary Prepayment Of USD 75 Million Term Loan, Equivalent To Rs. 626 Cr.
Disclosure for voluntary prepayment of USD 75 million term loan, equivalent to Rs. 626 Cr.
12 Jun 2024
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investors/ Analysts Meeting
07 Jun 2024
Jubilant Pharmova Ltd - 530019 - Intimation Under Regulation 30 - Communication From USFDA
Intimation under Regulation 30 - COmmunication from USFDA
